The cascade of care for hepatitis C in Victoria, Australia: a data linkage cohort study
Internal Medicine Journal · 2024
DOI: 10.1111/imj.16361 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Internal Medicine Journal, 2024. Verfasst von Kathryn Snow und 4 weiteren Autor:innen. Beteiligte Einrichtung: WHO Collaborating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Hepatitis C. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Royal Melbourne Hospital Foundation.
Abstract (Originalsprache)
Background
Highly effective hepatitis C therapies are available in Australia. However, people living with hepatitis C face various barriers to accessing care and treatment.
Aims
To identify gaps in the cascade of care for hepatitis C and generate estimates of the number living with untreated infection according to population group, using a representative longitudinal study population.
Methods
We linked hepatitis C notification data from Victoria to national pathology, prescribing and death registry data. We assessed receipt of key clinical services in a large cohort who tested positive for hepatitis C from 1 January 2000 to 31 December 2016, with follow‐up to 30 June 2018. We estimated the number still living with hepatitis C, adjusting for spontaneous clearance and mortality.
Results
The cohort comprised 45 391 people positive for hepatitis C. Of these, 13 346 (29%) received treatment and an estimated 28% (95% confidence interval (CI): 26–30%) were still living with chronic infection at 30 June 2018, with the remainder still living following spontaneous clearance (30%, 95% CI: 29–32%) or having died (12%, 95% CI: 12–12%). Half (50%) of those still living with hepatitis C were born from 1965 to 1980, and 74% first tested positive before 2011.
Conclusions
Despite an enabling policy environment and subsidised therapy, many people in this cohort were not treated. Increased measures may be needed to engage people in care, including those who acquired hepatitis C more than 10 years ago.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- WHO Collaborating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
- Department of Infectious Diseases, University of Melbourne, Melbourne, Victoria, Australia.
- Victorian Government Department of Health, Melbourne, Victoria, Australia.
- School of Population Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
- Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
ORCID-Profile: Jennifer H MacLachlan
Förderung
- Royal Melbourne Hospital Foundation
Zitieren
APA
Snow, K., MacLachlan, J. H., Rowe, S., Higgins, N., & Cowie, B. C. (2024). The cascade of care for hepatitis C in Victoria, Australia: a data linkage cohort study. Internal Medicine Journal. https://doi.org/10.1111/imj.16361
Vancouver
Snow K, MacLachlan JH, Rowe S, Higgins N, Cowie BC. The cascade of care for hepatitis C in Victoria, Australia: a data linkage cohort study. Internal Medicine Journal. 2024. doi:10.1111/imj.16361
BibTeX
@article{Snow2024,
author = {Snow, Kathryn and MacLachlan, Jennifer H and Rowe, Stacey and Higgins, Nasra and Cowie, Benjamin C},
title = {The cascade of care for hepatitis C in Victoria, Australia: a data linkage cohort study},
journal = {Internal Medicine Journal},
year = {2024},
doi = {10.1111/imj.16361}
}
EUVIMED